Figure 1.
Cumulative total cost difference (BORT minus LEN/DEX) (USD). Excess costs principally due to higher medical and AE management costs for BORT (BORT, bortezomib; DEX, dexamethasone; LEN, lenalidomide).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.